2023-11-20 LIDR WG Meeting Notes

Hung Luu

Children’s

Riki Merrick

Vernetzt, APHL

Andrea Pitkus

UW

Pam Banning

3M

Xavier Gansel

Biomerieux

Amy McCormick

Epic

Dan Rutz

Epic

Rob Rae

CAP

Rob Hausam

Hausam Consulting

Sandy Jones

CDC

Stan Huff

Graphite

Ed Heierman

Abbott / IICC

Andrew Quinn

Laurent Lardin

Biomerieux

Anthony Killeen

UMN

Craig Collom

Marti Velezis

 Sonrisa / FDA

Walter Sujansky

FDA

Susan Downer

JMC

Ralf Herzog

Roche

Cornelia Felder

Roche

Daniel Golson

JMC

Andrea Prada

JMC

Maria Sagat

Reviewing minutes from the last call - Action Item Follow up

• Pull out the definitions from LIVD for test kit and equipment and put here: SHIELD Glossary

• UDI presentation - link to recording: Watch the Recording - passcode = %jP0B?^^

• Outreach to Dr. DeBaca

  • Hung will check for more info and maybe see, if she could participate in SHIELD

• Hung is still working on the examples

• Waiting for response from Ed

• Keep updating the googlesheet: Potassium Analyzers

How can we start doing some actual work?

Have LIVD File Repository Requirements

Have draft budget (for setting up a web-based database and yearly maintenance): https://aphlinformatics.atlassian.net/wiki/download/attachments/915407143/LIDR - Budget.xlsx?api=v2

• Set up googlesheet to collect the data: Potassium Analyzers

  • Plan is to work on the serum based Potassium tests first, add spot urine and then deal with timed samples after that

  • For the mapping it wold be good to include a date mapped (we do have “Publication Version”, but that is not always providing the date) - add column to capture Mapping Date

Solidify Requirements for inclusion in the White Paper

• Review the LIDR Use Cases and prioritize them

  • Please sign up to lead one of these use cases

  • Discussion around PH Use Case:

    • Riki was approached by PHAs to consider crowdsourcing the creation of a LIVD file for reportable conditions

    • manufacturer should be the source of truth

    • for manufacturers that are not providing content other should be able to add their test to LIDR

      • add a column to indicate who provided the input

    • We should be sure that only reviewed content is published - otherwise this will not be authoritative

      • add a column to indicate if mapping was reviewed - by committee and by manufacturer

    • some LOINCs may not be used specifically in the US, but if results from non-US testing are reported, then the appropriate LOINC should be used

    • Desire by PH to have just a single LOINC is counterproductive to the desire to have the most granular LOINC mapped for a test in the clinical space - so that;s what we MUST support

    • Do we include a mapping of the test to the relevant clinical condition if it is reportable?

      • PH already has these tools:

        • Reportable Condition Mapping Tables (RCMT) - mapps each LOINC to a reportable condition and each SNOMED CT code to a reportable condition - was maintained by CDC, not sure if still updating

        • Reportable Condition Triger Codes (RCTC) - map LOINC, SNOMED CT, RXNorm and ICD codes to reportable conditions - maintained by CSTE

        • Reportable Condition Knowledge Management (RCKMS) - provides the rules for each jurisdiction for both case reporting (eCR) and lab reporting (ELR) for instance reporting determination based on CDA transmissions, so currently ONLY eCR - maintained by CSTE

      • Not every entry would have this, so not ideal and also a duplication of tooling / effort, so not a good data element to add

• Set deliverables and milestone dates

  • White Paper - outline with content stubbed in by end of Dec 2023

    • Publish White Paper Q1 of 2024

    • Journal Articles pointing to White Paper Q2 2024

• LIDR has 2 apsects

  • technical

  • content - see discussion about this part above

LOINC - SNOMED Collaboration

• The SNOMED extenstion which will represent LOINCs can be helpful in sorting through LIDR entries, Stan could make presentation - suggest as a topic for the SHIELD call #2 Special Topic call

Next Steps

• Sign up for sections to provide draft content on the LIDR White Paper

• Review LIDR Use Cases and sign up to lead one of these

Next call

Monday 11/27/2023 9 - 10 AM ET

Adjourned

10:03 AM ET